Clifutinib Besylate
PCD-DHEC73543-16-001
Phase 1 small_molecule completed
Quick answer
Clifutinib Besylate for Acute Myeloid Leukemia is a Phase 1 program (small_molecule) at Sunshine Biopharma with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Sunshine Biopharma
- Indication
- Acute Myeloid Leukemia
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed